3Rossi G.ProPhylaxis with lamivudine of hepatitis B virus reaetivation in chronic HBsAg carriers with hemoto-oncological neoplasias treated with chemotherapy. LeuK Lymphoma, 2003, 44:759.
4Yeo W, Johnson PJ. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.Hepatology, 2006, 43:209.
5Yeo W,Chan PK,Hui P, et al.Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy:a prospec-five study. J Med Virol, 2003, 70:553.
6Hsu CH, Hsu HC, Chen HL, et al. Doxorubicin activates hepatitis B virus (HBV) replication in HBV harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy. Anticancer Res, 2004, 24:3035.
7Cheng AL.Steroid free chemotherapy decreases the risk of hepatitis flare up in hepatitis B virus carriers with non-Hodgkin's lymphoma. Blood, 1996, 87:1202.
8Lazdina U, Alheim M, Nystrom J, et al. Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent. J Gen Virol, 2003, 84:139.
9Chou CK, Wang LH, Lin HM, et al.Glucocorticoid stimulates hepatitis B viral gene expression in cultured human hepatomacells. Hepatology, 1992, 16:13.
10Lau GK,Yiu HH, Fong DY, et al. Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy. Gastroenterology, 2003, 125:1742.
